Stonepine Capital Management, LLC 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 10:55 am Sale | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | Stonepine Capital Management, LLC | 6,940,000 3.100% | -2,971,577 (-29.98%) | Filing |
| 2022-02-14 08:21 am Sale | 2021-12-31 | 13G | ADMA Biologics, Inc. ADMA | Stonepine Capital Management, LLC | 9,911,577 5.100% | -61,300 (-0.61%) | Filing |
| 2021-12-30 12:26 pm Purchase | 2021-12-28 | 13G | ADMA Biologics, Inc. ADMA | Stonepine Capital Management, LLC | 9,972,877 5.100% | 9,972,877 (New Position) | Filing |